Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Home
Dr. Michael Belin
Dr. Michael Belin
26 Feb 2018
Share:
More great content like this
- straight to your inbox >
Related To This Subject
Neurology
12th
May
The American Medical Journal Editorial Board
Neurology
12th
May
Dr Rajiv R. Ratan
More articles
Dermatology
12 Sep 2025
The POSITIVE Phase IV Study: Interim 52-Week Results on Patient Well-Being With Tildrakizumab
Cardiology
4
Mins
11 Sep 2025
Renal Angioplasty and Stenting for Atherosclerotic Renal Artery Stenosis
Oncology
11 Sep 2025
FDA Approves IMFINZI Plus Carboplatin and Paclitaxel for Certain Patients With Endometrial Cancer
Featured journals
Flagship Journal
September 2025
EMJ 10.3 2025
Allergy & Immunology
September 2025
EMJ Allergy & Immunology 10 [Supplement 5] 2025
We’ve noticed you’re accessing
from
North/South America.
View
View
